More importantly, the Kaplan-Meier analysis revealed that patients with higher GAU1 expression had worse prognosis (P = 3.04 × 10−2, Figure 1(d)), indicating GAU1 may play an oncogenic role in CRC. This evidence concerns the gene GAU1 and colorectal carcinoma.